FDA pharmacologic class

Anthracycline Topoisomerase Inhibitor

4 medicines are in FDA's class of anthracycline topoisomerase inhibitors: doxorubicin (Doxil), idarubicin (Idamycin), daunorubicin and epirubicin (Ellence); 1 combination product also contains one. 3 of the 5 are listed from generic labelers (FDA NDC Directory, October 8, 2026).

Which medicines are anthracycline topoisomerase inhibitor?

Recalls: FDA enforcement reports, 2012 on
Medicine	Brand names	Generic labelers (all forms)	Pharmacy cost	Boxed warning	Shortage	Recalls since 2012
Doxorubicin	Doxil	16 labelers	n/a	Yes	No current entry	5
Idarubicin	Idamycin	2 labelers	n/a	Yes	No current entry	1
Daunorubicin	none listed	2 labelers	n/a	Yes	No current entry	2
Epirubicin	Ellence	none listed	n/a	Yes	No current entry	0
Cytarabine and daunorubicin	Vyxeos	none listed	n/a	Yes	No current entry	0

Source: FDA Established Pharmacologic Class (NDC Directory, openFDA); CMS NADAC of October 7, 2026; FDA shortages and recalls (FDA files October 8, 2026)

What next?

Every drug class
Medicines A to Z